“STUDY OF THE HYPOGLYCEMIC AND CARDIOPROTECTIVE EFFECT OF EMPAGLIFLOZIN IN THERAPY OF PATIENTS WITH TYPE 2 DIABETES MELLITUS” (2023) World Bulletin of Public Health, 18, pp. 9–14. Available at: https://scholarexpress.net/index.php/wbph/article/view/1965 (Accessed: 3 February 2026).